Tibet Aim Pharm (SZSE:002826) Accounts Payable & Accrued Expense : ¥165.1 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm Accounts Payable & Accrued Expense?

Tibet Aim Pharm's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥205.2 Mil) to Dec. 2023 (¥156.1 Mil) but then increased from Dec. 2023 (¥156.1 Mil) to Mar. 2024 (¥165.1 Mil).

Tibet Aim Pharm's annual accounts payable & accrued expense declined from Dec. 2020 (¥124.8 Mil) to Dec. 2021 (¥88.9 Mil) but then increased from Dec. 2021 (¥88.9 Mil) to Dec. 2022 (¥207.2 Mil).

Tibet Aim Pharm Accounts Payable & Accrued Expense Historical Data

The historical data trend for Tibet Aim Pharm's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm Accounts Payable & Accrued Expense Chart

Tibet Aim Pharm Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

90.01

105.05

124.78

88.91

207.21

Tibet Aim Pharm Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															196.01	194.58	205.23	156.10	165.14

Tibet Aim Pharm Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Tibet Aim Pharm (SZSE:002826) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000

Website

http://www.emyy.cn

Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.

Executives

Peng Hui	Director
Pang Guo Qiang	Directors, executives
Li Qian Jin	Securities Affairs Representative
Liu Hang	Supervisors

Tibet Aim Pharm (SZSE:002826) Headlines

No Headlines